Taiwan has ramped up production and imports of the main drug used to treat mycoplasma pneumoniae in children, amid a surge in cases of the respiratory illness reported in China in recent weeks, the Taiwan Food and Drug Administration (TFDA) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Concerns raised over elderly drivers raised following fatal car crash
05/20/2025 07:11 PM - Society
Flowers pile up at fatal car crash scene in New Taipei
05/20/2025 07:09 PM - Cross-Strait
2 Chinese men on makeshift rafts off Taiwan's Erdan Island detained
05/20/2025 06:38 PM - Business
Taiwan shares end flat as TSMC gives up earlier gains
05/20/2025 05:39 PM - Science & Tech
Hon Hai showcases 'Foxconn Genesis' robotics platform at Computex 2025
05/20/2025 05:22 PM